Literature DB >> 18032838

Longitudinal epidemiology of Chlamydia trachomatis serovars in female patients in Japan.

Syun Takahashi1, Tsutomu Yamazaki, Kozue Satoh, Miyuki Inoue, Sachiko Takahashi, Osamu Ishihara, Yohko Oka, Yuji Horiguchi, Yoshiyuki Okuwaki, Satowa Suzuki, Toshio Kishimoto.   

Abstract

The objective of this study was to clarify the longitudinal epidemiology of Chlamydia trachomatis serovars in Japan. A total of 339 endocervical swab specimens obtained from female patients who attended the Department of Obstetrics and Gynecology, Saitama Medical School, were used. Positive specimens of either transport medium of IDEIA Chlamydia (1st group, from 1999 to 2001), or DNA extract of Cobas Amplicor STD-1 Chlamydia trachomatis (2nd group, from 2003 to 2005) were used for serotyping. Typing of C. trachomatis serovars in DNA extracts was performed by polymerase chain reaction-restriction fragment length polymorphism. Ten serovars, A, B, D, E, F, G, H, I, J and K, were identified in the 1st group, and serovar E was most frequently identified (27.6%). In the 2nd group, nine serovars, B, C, D, E, F, G, H, I and K, were identified, and serovar D was most frequently identified (24.7%). Serovars B and Ba were significantly more common around 2000 and the mid-1990s (from 1993 to 1996), respectively. Numbers of serovar I increased significantly during the research period. In addition, serovar I was more frequent in the 2nd group than in the 1st group in women aged 20-29 years. There were no significant differences of serovar distribution between pregnant and non-pregnant women.

Entities:  

Mesh:

Year:  2007        PMID: 18032838

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  1 in total

1.  Chlamydia trachomatis genotypes in a cross-sectional study of urogenital samples from remote Northern and Central Australia.

Authors:  Philip M Giffard; Nicole C Brenner; Sepehr N Tabrizi; Suzanne M Garland; Deborah C Holt; Patiyan Andersson; Rachael A Lilliebridge; Steven Y C Tong; Mahdad Karimi; Prudence Boylan; Nathan Ryder; Tracy Johns; Gurmeet Singh
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.